Accretion Pharmaceuticals Limited (NSE:ACCPL)

India · Delayed Price · Currency is INR

202.30

-5.70 (-2.74%)

At close: Aug 21, 2026

Accretion Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	896.27	896.27	573.76	133.53	295.32	225.84
Revenue Growth	8.45%	56.21%	329.70%	-54.79%	30.76%	-
Gross Profit	239.81	239.81	173.55	39.17	55.21	45.91
Operating Income	138.48	138.48	111.29	23.58	12.15	11.21
Net Income	96.68	96.68	67.94	14.93	1.04	0.79
Earnings Per Share	9.03	9.03	8.48	1.96	-	-
EPS Growth	-8.07%	6.54%	332.43%	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	819.63	819.63	526.12	123.81	293.33	222.92
outside India	76.64	76.64	47.64	9.72	-	-
Total	896.27	896.27	573.76	133.53	293.84	222.92

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	40.21	40.21	0.51	0.92	0.36	3.75
Total Debt	123.21	123.21	141.04	134.78	84.66	76.08
Net Cash (Debt)	-83.01	-83.01	-140.53	-133.86	-84.29	-72.33
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-7.75	-7.75	-17.53	-17.61	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-145.34	-145.34	-6.19	-115.09	3.21	21.5
Capital Expenditures	-85.34	-85.34	-16.11	-54.78	-11.78	-2.57
Free Cash Flow	-230.68	-230.68	-22.3	-169.87	-8.57	18.93
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	26.76%	26.76%	30.25%	29.33%	18.70%	20.33%
Operating Margin	15.45%	15.45%	19.40%	17.66%	4.12%	4.96%
Pretax Margin	14.60%	14.60%	17.02%	14.94%	0.47%	0.46%
Profit Margin	10.79%	10.79%	11.84%	11.18%	0.35%	0.35%
FCF Margin	-25.74%	-25.74%	-3.89%	-127.22%	-2.90%	8.38%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 23, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	22.40	7.31	-	-	-	-
PS Ratio	2.51	0.79	-	-	-	-